Drugzone announced a strategic initiative to prioritize adherence to the Drug Supply Chain Security Act (DSCSA) that mandates a system to track and trace prescription medications throughout the United States.
This move is particularly significant, ensuring that all distributed pharmaceutical products meet stringent regulatory requirements, thereby safeguarding against counterfeit and substandard medications entering the supply chain.

Being recognized as one of the leading pharmaceutical distribution companies, Drugzone maintains that it considers it a crucial duty to set precedents in compliance and reliability within the sector.

To further its dedication to DSCSA adherence and solidify its commitment to patient safety, the Company is investing in cutting-edge technology and ongoing staff training. This initiative includes the implementation of advanced serializations and tracking systems designed to ensure full traceability of pharmaceutical products from the manufacturer to the pharmacy.

This approach not only enhances Drugzone's capability to meet DSCSA standards but also positions the company as a leader in fostering a safer and more transparent pharmaceutical supply chain. Over the years, Drugzone has successfully established itself as a leading supplier in the pharmaceutical distribution market, with a focus on offering a broad selection of generic drugs to a diverse range of customers across the United States.

Its latest emphasis on DSCSA adherence not only demonstrates Drugzone's dedication to compliance but also reflects its holistic approach to strengthening patient safety protocols across its distribution networks.

For further information, please visit www.drugzone.com